Abstract
Adamantinomatous craniopharyngioma (ACP) is an aggressive brain tumor that occurs predominantly in the pediatric population. Conventional diagnosis method and standard therapy cannot treat ACPs effectively. In this paper, we aimed to identify key genes for ACP early diagnosis and treatment. Datasets GSE94349 and GSE68015 were obtained from Gene Expression Omnibus database. Consensus clustering was applied to discover the gene clusters in the expression data of GSE94349 and functional enrichment analysis was performed on gene set in each cluster. The protein–protein interaction (PPI) network was built by the Search Tool for the Retrieval of Interacting Genes, and hubs were selected. Support vector machine (SVM) model was built based on the signature genes identified from enrichment analysis and PPI network. Dataset GSE94349 was used for training and testing, and GSE68015 was used for validation. Besides, RT-qPCR analysis was performed to analyze the expression of signature genes in ACP samples compared with normal controls. Seven gene clusters were discovered in the differentially expressed genes identified from GSE94349 dataset. Enrichment analysis of each cluster identified 25 pathways that highly associated with ACP. PPI network was built and 46 hubs were determined. Twenty-five pathway-related genes that overlapped with the hubs in PPI network were used as signatures to establish the SVM diagnosis model for ACP. The prediction accuracy of SVM model for training, testing, and validation data were 94, 85, and 74%, respectively. The expression of CDH1, CCL2, ITGA2, COL8A1, COL6A2, and COL6A3 were significantly upregulated in ACP tumor samples, while CAMK2A, RIMS1, NEFL, SYT1, and STX1A were significantly downregulated, which were consistent with the differentially expressed gene analysis. SVM model is a promising classification tool for screening and early diagnosis of ACP. The ACP-related pathways and signature genes will advance our knowledge of ACP pathogenesis and benefit the therapy improvement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rodriguez FJ, Scheithauer BW, Tsunoda S, Kovacs K, Vidal S, Piepgras DG. The spectrum of malignancy in craniopharyngioma. Am J Surg Pathol. 2007;31:1020–8.
Garrè ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr. 2007;19:471–9.
Garnett MR, Puget S, Grill J, Sainte-Rose C. Craniopharyngioma. Orphanet J Rare Dis. 2007;2:18.
Hamid R, Sarkar S, Hossain M, Mazumder U, Akanda N, Parvin R. Clinical picture of craniopharyngioma in childhood. Mymensingh Med J. 2007;16:123–6.
Özyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, et al. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr. 2014;164:876–81. e874.
Sughrue ME, Yang I, Kane AJ, Fang S, Clark AJ, Aranda D, et al. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol. 2011;101:463–76.
Flitsch J, Müller HL, Burkhardt T. Surgical strategies in childhood craniopharyngioma. Front Endocrinol. 2011;2:96.
Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, et al. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun. 2015;3:30.
Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AM, Müller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol. 2015;17:1029–38.
Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46:161–5.
Larkin SJ, Preda V, Karavitaki N, Grossman A, Ansorge O. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol. 2014;127:927–9.
Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, et al. Craniopharyngiomas of adamantinomatous type harbor β-catenin gene mutations. Am J Pathol. 2002;161:1997–2001.
Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203:814–21.
Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrübl F, et al. Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109:589–97.
Oikonomou E, Barreto DC, Soares B, De Marco L, Buchfelder M, Adams EF. β-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol. 2005;73:205–9.
Malgulwar PB, Nambirajan A, Pathak P, Faruq M, Suri V, Sarkar C, et al. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases. J Neurooncol. 2017;133(3):487–495.
Zhang G.A modified SVM classifier based on RS in medical disease prediction. Computational Intelligence and Design, 2009. ISCID'09. Second International Symposium on IEEE; 2009.
Maji S, Berg AC, Malik J. Efficient classification for additive kernel SVMs. IEEE Trans Pattern Anal Mach Intell. 2013;35:66–77.
Thurston RC, Matthews KA, Hernandez J, De La Torre F. Improving the performance of physiologic hot flash measures with support vector machines. Psychophysiology. 2009;46:285–92.
Zhang B, Liang X, Gao H, Ye L, Wang Y. Models of logistic regression analysis, support vector machine, and back-propagation neural network based on serum tumor markers in colorectal cancer diagnosis. Genet Mol Res. 2016;15,gmr.15028643.
Yu W, Liu T, Valdez R, Gwinn M, Khoury MJ. Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak. 2010;10:16.
Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn. 2003;5:73–81.
Diboun I, Wernisch L, Orengo CA, Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genom. 2006;7:252.
Bishara AJ, Hittner JB. Testing the significance of a correlation with nonnormal data: comparison of Pearson, Spearman, transformation, and resampling approaches. Psychol Methods. 2012;17:399.
Gu J, Pitz M, Breitner S, Birmili W, von Klot S, Schneider A, et al. Selection of key ambient particulate variables for epidemiological studies—applying cluster and heatmap analyses as tools for data reduction. Sci Total Environ. 2012;435:541–50.
Han Y, Lu W, Chen T. Cluster consensus in discrete-time networks of multiagents with inter-cluster nonidentical inputs. IEEE Trans Neural Netw Learn Syst. 2013;24:566–78.
Xue B, Oldfield CJ, Dunker AK, Uversky VN. CDF it all: consensus prediction of intrinsically disordered proteins based on various cumulative distribution functions. FEBS Lett. 2009;583:1469–74.
Lumijärvi J, Laurikkala J, Juhola M. A comparison of different heterogeneous proximity functions and Euclidean distance. Stud Health Technol Inform. 2004;107:1362–6.
Kim TK. T test as a parametric statistic. Korean J Anesthesiol. 2015;68:540–6.
Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2010;39:D561–8.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.
Tang Y, Li M, Wang J, Pan Y, Wu F-X. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67–72.
American Medical Informatics Association. Outlier detection with one-class SVMs: an application to melanoma prognosis. AMIA Annual Symposium Proceedings. American Medical Informatics Association;US, 2010.
Durbeej M. Laminins. Cell Tissue Res. 2010;339:259.
Tena-Suck ML, Salinas-Lara C, Arce-Arellano RI, Rembao-Bojórquez D, Morales-Espinosa D, Sotelo J, et al. Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas. Clin Neurol Neurosurg. 2006;108:661–9.
Colli LM, Saggioro F, Serafini LN, Camargo RC, Machado HR, Moreira AC, et al. Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors. PLoS ONE. 2013;8:e62424.
Yamauchi T. Neuronal Ca2 + /calmodulin-dependent protein kinase II—discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull. 2005;28:1342–54.
Najdi R, Syed A, Arce L, Theisen H, Ting J-HT, Atcha F, et al. A Wnt-kinase network alters nuclear localization of TCF-1 in colon cancer. Oncogene. 2009;28:4133.
Thomas DM, Ferguson GD, Herschman HR, Elferink LA. Functional and biochemical analysis of the C2 domains of synaptotagmin IV. Mol Biol Cell. 1999;10:2285–95.
Ciani L, Marzo A, Boyle K, Stamatakou E, Lopes DM, Anane D, et al. Wnt signalling tunes neurotransmitter release by directly targeting Synaptotagmin-1. Nat Commun. 2015;6,8302.
Pérez-Palma E, Andrade V, Caracci MO, Bustos BI, Villaman C, Medina MA, et al. Early transcriptional changes induced by Wnt/β-Catenin signaling in hippocampal neurons. Neural Plast. 2016;2016,4672841.
Rampazzo E, Persano L, Pistollato F, Moro E, Frasson C, Porazzi P, et al. Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis. 2013;4:e500.
Hölsken A, Sill M, Merkle J, Schweizer L, Buchfelder M, Flitsch J, et al. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun. 2016;4:20.
Song‐tao Q, Xiao‐rong Y, Jun P, Yong‐jian D, Jin L, Guang‐long H, et al. Does the calcification of adamantinomatous craniopharyngioma resemble the calcium deposition of osteogenesis/odontogenesis? Histopathology. 2014;64:336–47.
Farrell WE, Azevedo MF, Batista DL, Smith A, Bourdeau I, Horvath A, et al. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma. J Clin Endocrinol Metab. 2011;96:E1905–14.
Apps JR, Jani N, Carreno G, Gonzalez-Meljem JM, Tossell K, Stone TJ, et al. Expression analysis of adamantinomatous craniopharyngioma suggests two subtypes associated with CTNNB1 mutational frequency and highlights potential therapeutic targets. In: AACR; 2016.
Apps J, Carreno G, Boult J, Gutteridge A, Danielson L, Jani N, et al. Molecular profiling and preclinical targeted therapeutic testing in adamantinomatous craniopharyngioma. Lancet. 2017;389:S22.
Xu L, Warren M, Rose W, Gong W, Wang J. Human recombinant monocyte chemotactic protein and other CC chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol. 1996;60:365–71.
Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013;19:739–46.
Gong A-X, Zhang J-H, Li J, Wu J, Wang L, Miao D-S. Comparison of gene expression profiles between dental pulp and periodontal ligament tissues in humans. Int J Mol Med. 2017;40:647–60.
Muller C, Adroos N, Lockhat Z, Slavik T, Kruger H. Toothy craniopharyngioma: a literature review and case report of craniopharyngioma with extensive odontogenic differentiation and tooth formation. Child Nerv Syst. 2011;27:323–6.
Beaty NB, Ahn E. Adamantinomatous craniopharyngioma containing teeth. N Engl J Med. 2014;370:860–860.
Plenz GA, Deng MC, Robenek H, Völker W. Vascular collagens: spotlight on the role of type VIII collagen in atherogenesis. Atherosclerosis. 2003;166:1–11.
Bertini E, Pepe G. Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Eur J Paediatr Neurol. 2002;6:193–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Yang, J., Hou, Z., Wang, C. et al. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma. Cancer Gene Ther 25, 227–239 (2018). https://doi.org/10.1038/s41417-018-0015-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-018-0015-4
This article is cited by
-
Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
BMC Cancer (2023)
-
Expression of TXLNA in brain gliomas and its clinical significance: a bioinformatics analysis
Chinese Neurosurgical Journal (2023)
-
GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
Cancer Cell International (2021)
-
Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis
Cancer Cell International (2020)
-
COL6A3 polymorphisms were associated with lung cancer risk in a Chinese population
Respiratory Research (2019)